Home > Income Statement > GLAND PHARMA

GLAND PHARMA
Consolidated Net Profit

    Back to Income Statement
GLAND PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Consolidated Net Profit ₹781 Cr₹1,212 Cr₹997 Cr₹773 Cr₹773 Cr

What is the latest Consolidated Net Profit of GLAND PHARMA ?

The latest Consolidated Net Profit ratio of GLAND PHARMA is ₹781 Cr based on Mar2024 Consolidated results.
Year Consolidated Net Profit
Mar2024₹781 Cr
Mar2023₹1,212 Cr
Mar2022₹997 Cr
Mar2021₹773 Cr
Mar2020₹773 Cr

How is Consolidated Net Profit of GLAND PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2024 ₹781 Cr
-35.54
Mar2023 ₹1,212 Cr
21.54
Mar2022 ₹997 Cr
29.00
Mar2021 ₹773 Cr
0.00
Mar2020 ₹773 Cr -

Compare Consolidated Net Profit of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹32,973.2 Cr 5.9% 17.1% -2.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,267.0 Cr 0.7% 2.8% 7.9% Stock Analytics
DIVIS LABORATORIES ₹178,672.0 Cr -0.8% 3.7% 48.6% Stock Analytics
CIPLA ₹119,713.0 Cr -0.2% -0.1% -1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,195.0 Cr 3.4% 11.2% 17.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,999.0 Cr 0.6% -5.2% -4.9% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

5.9%

17.1%

-2.2%

SENSEX

-0.9%

0.4%

1.4%


You may also like the below Video Courses